Three new caproKits™ help enable the discovery, identification, and characterization of proteins for applications in functional proteomics and drug development. These new kits are the Dasatinib caproKit, the C2 CAMP caproKit, and the Biotin Capping Kit. CaproKits are based on capture compound mass spectrometry technology, a direct way to investigate small molecule/protein interactions. Capture Compounds™ enable the direct isolation and identification of defined protein classes, including membrane proteins, out of complex biological samples. The new and existing caproKits target different areas of research ranging from signal transduction to epigenetics and proteases. The Dasatinib and C2 cAMP caproKits are the newest additions to the company's signal-transduction product line. The Biotin Capping Kit is used to improve analytical performance by decreasing background noise when study samples contain a high amount of naturally biotin-modified proteins.